SCHEDULE 13G/A

NEKTAR THERAPEUTICS

Common Stock, $0.0001 par value · CUSIP: 640268108

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Eventide Asset Management, LLC

  Shares: 6,650,000.00 · Class: 3.61%

• Finny Kuruvilla, M.D., Ph. D.

  Shares: 6,650,000.00 · Class: 3.61%

• Robin C. John

  Shares: 6,650,000.00 · Class: 3.61%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.